CG
Carmignac Gestion’s ResMed RMD Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-8,376
| Closed | -$1.24M | – | 151 |
|
|
2023
Q3 | $1.24M | Sell |
8,376
-15,263
| -65% | -$2.26M | 0.02% | 114 |
|
|
2023
Q2 | $5.16M | Sell |
23,639
-10,257
| -30% | -$2.24M | 0.09% | 73 |
|
|
2023
Q1 | $7.38M | Buy |
33,896
+809
| +2% | +$176K | 0.12% | 63 |
|
|
2022
Q4 | $6.9M | Buy |
33,087
+350
| +1% | +$73K | 0.12% | 63 |
|
|
2022
Q3 | $7.15M | Buy |
32,737
+7,668
| +31% | +$1.68M | 0.15% | 54 |
|
|
2022
Q2 | $5.28M | Sell |
25,069
-5,578
| -18% | -$1.18M | 0.11% | 61 |
|
|
2022
Q1 | $7.5M | Sell |
30,647
-6,101
| -17% | -$1.49M | 0.12% | 58 |
|
|
2021
Q4 | $9.59M | Buy |
36,748
+15,181
| +70% | +$3.96M | 0.13% | 63 |
|
|
2021
Q3 | $5.69M | Buy |
21,567
+1,400
| +7% | +$370K | 0.07% | 85 |
|
|
2021
Q2 | $4.97M | Sell |
20,167
-6,607
| -25% | -$1.63M | 0.06% | 89 |
|
|
2021
Q1 | $5.15M | Buy |
26,774
+12,973
| +94% | +$2.5M | 0.06% | 83 |
|
|
2020
Q4 | $2.92M | Buy |
13,801
+578
| +4% | +$122K | 0.03% | 92 |
|
|
2020
Q3 | $2.27M | Buy |
13,223
+122
| +0.9% | +$20.9K | 0.03% | 91 |
|
|
2020
Q2 | $2.51M | Buy |
13,101
+3,959
| +43% | +$758K | 0.03% | 80 |
|
|
2020
Q1 | $1.35M | Buy |
9,142
+5,295
| +138% | +$780K | 0.02% | 86 |
|
|
2019
Q4 | $596K | Buy |
3,847
+1,791
| +87% | +$277K | 0.01% | 104 |
|
|
2019
Q3 | $278K | Buy |
2,056
+89
| +5% | +$12K | ﹤0.01% | 109 |
|
|
2019
Q2 | $240K | Buy |
+1,967
| New | +$240K | ﹤0.01% | 107 |
|